Oncology

Follow this topic Ask about this topic

Momentum

8 papers in the last four weeks, down 50% on the four weeks before. 0.1% of all new papers.

Jul 13Week of Sep 28

Latest papers 212

May 1, 2026cs.CV

CURE-OOD: Benchmarking Out-of-Distribution Detection for Survival Prediction

``How long can I live and remain free of cancer?'' is often the first question a patient asks after receiving a cancer diagnosis and treatment. Accurate survival prediction helps alleviate psychological distress and supports risk stratification and personalized treatment planning. Recent survival prediction frameworks have shown strong performance using computed tomography (CT) images. However, variations in imaging acquisition introduce out-of-distribution (OOD) samples caused by covariate shifts that undermine model reliability. Despite this challenge, to our knowledge, no existing benchmark systematically studies OOD detection in cancer survival prediction. To address this gap, we introduce the Cancer sURvival bEnchmark for OOD Detection (CURE-OOD), the first benchmark for systematically evaluating OOD detection in survival prediction under controlled acquisition-induced distribution shifts. CURE-OOD defines scanner-parameter-based training, in-distribution (ID), and OOD test splits across four survival prediction tasks. Our experiments show that covariate shifts notably reduce survival prediction performance. It also shows that mainstream classification-oriented OOD detectors can fail in survival prediction. Finally, we include HazardDev as a simple survival-aware reference baseline for OOD detection. CURE-OOD enables systematic analysis of how distribution shifts affect both downstream survival performance and OOD detectability.

Wenjie Zhao, Jia Li, Mingrui Liu +2

University of Texas at Dallas · George Mason University · UT Southwestern Medical Center

Cancer Survival Prediction Distribution Shift Covariate Shift Oncology OOD Detection Medical Image Benchmarks

Apr 30, 2026cs.CV

Assessing Pancreatic Ductal Adenocarcinoma Vascular Invasion: the PDACVI Benchmark

Surgical resection remains the only potentially curative treatment for pancreatic ductal adenocarcinoma (PDAC), and eligibility depends on accurate assessment of vascular invasion (VI), i.e., tumor extension into adjacent critical vessels. Despite its importance for preoperative staging and surgical planning, computational VI assessment remains underexplored. Two major challenges are the lack of public datasets and the diagnostic ambiguity at the tumor-vessel interface, which leads to substantial inter-rater variability even among expert radiologists. To address these limitations, we introduce the CURVAS-PDACVI Dataset and Challenge, an open benchmark for uncertainty-aware AI in PDAC staging based on a densely annotated dataset with five independent expert annotations per scan. We also propose a multi-metric evaluation framework that extends beyond spatial overlap to include probabilistic calibration and VI assessment. Evaluation of six state-of-the-art methods shows that strong global volumetric overlap does not necessarily translate into reliable performance at clinically critical tumor-vessel interfaces. In particular, methods optimized for binary segmentation perform competitively on average overlap metrics, but often degrade in high-complexity cases with low expert consensus, either collapsing in volume or overextending at uncertain boundaries. In contrast, methods that model inter-rater disagreement produce better calibrated probabilistic maps and show greater robustness in these ambiguous cases. The benchmark highlights the limitations of volumetric accuracy as a proxy for localized surgical utility, motivating uncertainty-aware probabilistic models for preoperative decision-making.

M. Riera-Marín, O. K. Sikha, J. Rodríguez-Comas +23

BCN Medtech, Universitat Pompeu Fabra, Barcelona, Spain · Universitätsklinikum Erlangen, Department of Radiology of the Uniklinikum Erlangen (UKER), Erlangen, Germany · University Hospital Erlangen, Imaging Science Institute, Erlangen, Germany +10

Inter-Rater Reliability Medical Image Analysis Medical Image Segmentation Oncology Segmentation Uncertainty Estimation Medical Image Benchmarks

Apr 28, 2026cs.CV

Validation of Whole-Slide Foundation Models for Image Retrieval in TCGA Data

Foundation models are reshaping computational histopathology, yet their value for whole-slide image retrieval relative to strong patch-based and supervised aggregation baselines remains unclear. We benchmarked ten pipelines on 9,387 diagnostic slides spanning 17 organs and 60 diagnoses from The Cancer Genome Atlas (TCGA) using patient-level leave-one-patient-out evaluation. Methods included four pre-trained slide foundation models, a supervised attention-based multiple instance learning (ABMIL) aggregator on patch embeddings, and patch-level retrieval across five sampling densities. Performance varied more across organs and diagnoses than across architectures. Although the slide foundation model TITAN achieved the strongest overall results, its advantage was modest; ABMIL and patch-based methods reached comparable Top-1 and Top-3 accuracy, with no model consistently dominant. Morphologically distinctive entities approached ceiling performance, while rare, heterogeneous, and closely related subtypes remained challenging. Misclassifications aligned with organs exhibiting known inter-observer variability, suggesting an intrinsic ceiling for morphology-only retrieval. Performance was driven primarily by patch-level feature representations, with limited benefit from slide-level aggregation, indicating aggregation may be unnecessary in many settings. These findings argue against a universally optimal architecture and instead support organ-resolved benchmarking, diagnosis-aware or ensemble strategies, stronger feature representations, and multimodal retrieval frameworks. Notably, even the best model achieved only

\approx 68\% \pm 21\%

retrieval accuracy on TCGA, and some subtypes showed

0\%

accuracy across all methods, highlighting fundamental limitations of morphology-based representations and the need for substantial progress before reliable clinical deployment.

Tianhao Lei, Parsa Esmaeilkhani, Saghir Alfasly +5

KIMIA Lab, Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, USA. · Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Computer Science, Temple University, Philadelphia, PA, USA. +2

Pathology Foundation Models Oncology Medical Image Benchmarks Multiple Instance Learning Whole-Slide Image Analysis

Apr 27, 2026cs.CV

Benchmarking Pathology Foundation Models for Breast Cancer Survival Prediction

Pathology foundation models (PFMs) have recently emerged as powerful pretrained encoders for computational pathology, enabling transfer learning across a wide range of downstream tasks. However, systematic comparisons of these models for clinically meaningful prediction problems remain limited, especially in the context of survival prediction under external validation. In this study, we benchmark widely used and recently proposed PFMs for breast cancer survival prediction from whole-slide histopathology images. Using a standardized pipeline based on patch-level feature extraction and a unified survival modeling framework, we evaluate model representations across three independent clinical cohorts comprising more than 5,400 patients with long-term follow-up. Models are trained on one cohort and evaluated on two independent external cohorts, enabling a rigorous assessment of cross-dataset generalization. Overall, H-optimus-1 achieves the strongest survival prediction performance. More broadly, we observe consistent generational improvements across model families, with second-generation PFMs outperforming their first-generation counterparts. However, absolute performance differences between many recent PFMs remain modest, suggesting diminishing returns from further scaling of pretraining data or model size alone. Notably, the compact distilled model H0-mini slightly outperforms its larger teacher model H-optimus-0, despite using fewer than 8% of the parameters and enabling significantly faster feature extraction. Together, these results provide the first large-scale, externally validated benchmark of PFMs for breast cancer survival prediction, and offer practical guidance for efficient deployment of PFMs in clinical workflows.

Fredrik K. Gustafsson, Constance Boissin, Johan Vallon-Christersson +2

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden · Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden · Department of Engineering Science, University of Oxford, Oxford, UK +1

Cancer Survival Prediction Survival Analysis Pathology Foundation Models Oncology Medical Image Benchmarks Whole-Slide Image Analysis

Apr 27, 2026cs.AI

Agentic clinical reasoning over longitudinal myeloma records: a retrospective evaluation against expert consensus

Multiple myeloma is managed through sequential lines of therapy over years to decades, with each decision depending on cumulative disease history distributed across dozens to hundreds of heterogeneous clinical documents. Whether LLM-based systems can synthesise this evidence at a level approaching expert agreement has not been established. A retrospective evaluation was conducted on longitudinal clinical records of 811 myeloma patients treated at a tertiary centre (2001-2026), covering 44,962 documents and 1,334,677 laboratory values, with external validation on MIMIC-IV. An agentic reasoning system was compared against single-pass retrieval-augmented generation (RAG), iterative RAG, and full-context input on 469 patient-question pairs from 48 templates at three complexity levels. Reference labels came from double annotation by four oncologists with senior haematologist adjudication. Iterative RAG and full-context input converged on a shared ceiling (75.4% vs 75.8%, p = 1.00). The agentic system reached 79.6% concordance (95% CI 76.4-82.8), exceeding both baselines (+3.8 and +4.2 pp; p = 0.006 and 0.007). Gains rose with question complexity, reaching +9.4 pp on criteria-based synthesis (p = 0.032), and with record length, reaching +13.5 pp in the top decile (n = 10). The system error rate (12.2%) was comparable to expert disagreement (13.6%), but severity was inverted: 57.8% of system errors were clinically significant versus 18.8% of expert disagreements. Agentic reasoning was the only approach to exceed the shared ceiling, with gains concentrated on the most complex questions and longest records. The greater clinical consequence of residual system errors indicates that prospective evaluation in routine care is required before these findings translate into patient benefit.

Johannes Moll, Jannik Lübberstedt, Christoph Nuernbergk +21

Chair for AI in Healthcare and Medicine, Technical University of Munich (TUM) and TUM University Hospital, Munich, Germany · Department of Diagnostic and Interventional Radiology, Klinikum rechts der Isar, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany · Department of Cardiovascular Radiology and Nuclear Medicine, German Heart Center, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany +11

Healthcare LLM Agent Evaluation Clinical QA Clinical Reasoning Oncology Clinical Language Model Evaluation

Apr 27, 2026cs.LG

PathMoG: A Pathway-Centric Modular Graph Neural Network for Multi-Omics Survival Prediction

Cancer survival prediction from multi-omics data remains challenging because prognostic signals are high-dimensional, heterogeneous, and distributed across interacting genes and pathways. We propose PathMoG, a pathway-centric modular graph neural network for multi-omics survival prediction. PathMoG reorganizes genome-scale inputs into 354 KEGG-informed pathway modules, introduces a Hierarchical Omics Modulation module to condition gene-expression representations on mutation, copy number variation, pathway, and clinical context, and uses dual-level attention to capture both intra-pathway driver signals and inter-pathway clinical relevance. We evaluated PathMoG on 5,650 patients across 10 TCGA cancer types and observed consistent improvements over representative survival baselines. The framework further provides gene-level, pathway-level, and patient-level interpretability, supporting biologically grounded and clinically relevant risk stratification.

Di Wang, Chupei Tang, Junxiao Kong +3

1Cuiying Honors College, Lanzhou University, China · School of Mathematics and Statistics, Lanzhou University, China · School of Mathematics and Statistics, Lanzhou University, China and Shanghai Innovation Institute +1

Cancer Genomics Graph Neural Networks Cancer Survival Prediction Survival Analysis Oncology Modular Neural Networks

Apr 27, 2026cs.LG

CMGL: Confidence-guided Multi-omics Graph Learning for Cancer Subtype Classification

Motivation: Multi-omics integration can improve cancer subtyping, but modality informativeness and noise vary across cancer types and patients. Most graph methods for multi-omics data learn modality contributions within the downstream classification objective, leaving predictive reliability for each patient implicit. As a result, uninformative modalities can weaken the fused representation, while unreliable omics can introduce noisy patient relationships into graph propagation. To address these two problems, we propose CMGL, which produces a separate reliability estimate before fusion and uses consensus patient neighborhoods for graph classification. Results: CMGL estimates modality confidence for each patient through evidential deep learning, fixes these values during fusion across omics, and performs classification on an independently specified consistency graph. On four MLOmics cancer-subtype tasks and the 32-class pan-cancer task, CMGL consistently improves over the strongest baseline, surpassing it by 4.03% in average accuracy on the four single-cancer tasks. Its representations recover the PAM50 intrinsic subtypes of breast invasive carcinoma (BRCA), and the model trained on BRCA transfers without fine tuning to kidney renal clear cell carcinoma (KIRC), stratifying patients into prognostically distinct groups.

Boyang Fan, Hengchuang Yin, Siyu Yi +5

College of Computer Science, Sichuan University, Chengdu, China · Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, China · College of Mathematics, Sichuan University, Chengdu, China +1

Oncology Multimodal Graph Learning Multimodal Fusion

Apr 26, 2026cs.MA

EndoGov: A knowledge-governed multi-agent expert system for endometrial cancer risk stratification

Multimodal artificial intelligence models for endometrial cancer (EC) risk stratification typically optimize aggregate predictive performance but provide limited mechanisms for enforcing mandatory guideline overrides, such as assigning POLE-mutated tumors to the low-risk group despite high-grade morphology. We present EndoGov, a two-tier multi-agent expert system that factorizes the decision process as D(x) = G(P(x), R), where specialist agents P extract structured evidence and a governance agent G applies an executable rule set R. Tier 1 comprises pathology, molecular, and clinical agents that independently generate schema-constrained reports from frozen foundation-model features or structured records. Tier 2 queries an evidence-level-weighted Guideline Knowledge Graph, using deterministic hard-path rules for high-priority overrides and constrained soft-path reasoning for ambiguous cases. In TCGA-UCEC (n=541), EndoGov achieved 0.943 accuracy, 0.973 macro AUC, and a conditional logic-violation rate (C-LVR) of 0.93% among trigger-exposed cases. In CPTAC-UCEC (n=95), where reference labels are guideline-derived, EndoGov reached 0.842 accuracy compared with < 0.31 for locked-transfer neural baselines, supporting governance-pathway transfer under distribution shift rather than validation against independent clinical truth. End-to-end safety decomposition localized residual failures primarily to upstream molecular detection rather than downstream governance. Backend-swap experiments further showed that hard-path compliance is invariant to the LLM backend. These findings indicate that explicit clinical-rule governance can provide guideline-compliant, auditable EC risk assignment while preserving competitive discrimination.

Weiye Dai, Liyun Shi, Zanxiang He +4

aShenzhen Technology University, Shenzhen, China · bShenzhen People’s Hospital, Shenzhen, China · dShenzhen University, Shenzhen, China +1

Clinical Decision Support Multi-Agent Systems Oncology AI Agent Governance Clinical Risk Prediction

Apr 25, 2026eess.IV

CRC-SAM: SAM-Based Multi-Modal Segmentation and Quantification of Colorectal Cancer in CT, Colonoscopy, and Histology Images

We present CRC-SAM, a unified framework for colorectal cancer segmentation across colonoscopy, CT, and histopathology images. Unlike prior single-modality methods, CRC-SAM provides consistent, modality-agnostic segmentation throughout the clinical workflow. Built on MedSAM, it incorporates low-rank adaptation (LoRA) layers into a frozen encoder, enabling efficient domain transfer to underrepresented modalities with minimal trainable parameters. Experiments on MSD-Colon, CVC-ClinicDB, and EBHI-Seg demonstrate superior performance across modalities, outperforming state-of-the-art baselines and highlighting the effectiveness of lightweight LoRA adaptation for foundation-model-based colorectal cancer analysis.

Daniel Lao

Independent researcher

Cross-Modality Medical Image Segmentation Image Segmentation Medical Imaging Foundation Models Histopathology Image Segmentation Medical Image Segmentation Oncology

Apr 23, 2026cs.CV

Attention-based multiple instance learning for predominant growth pattern prediction in lung adenocarcinoma wsi using foundation models

Lung adenocarcinoma (LUAD) grading depends on accurately identifying growth patterns, which are indicators of prognosis and can influence treatment decisions. Common deep learning approaches to determine the predominant pattern rely on patch-level classification or segmentation, requiring extensive annotations. This study proposes an attention-based multiple instance learning (ABMIL) framework to predict the predominant LUAD growth pattern at the whole slide level to reduce annotation burden. Our approach integrates pretrained pathology foundation models as patch encoders, used either frozen or fine-tuned on annotated patches, to extract discriminative features that are aggregated through attention mechanisms. Experiments show that fine-tuned encoders improve performance, with Prov-GigaPath achieving the highest agreement (\k{appa} = 0.699) under ABMIL. Compared to simple patch-aggregation baselines, ABMIL yields more robust predictions by leveraging slide-level supervision and spatial attention. Future work will extend this framework to estimate the full distribution of growth patterns and validate performance on external cohorts.

Laura Valeria Perez-Herrera, M. J. Garcia-Gonzalez, Karen Lopez-Linares

* Vicomtech Foundation, Basque Research and Technology Alliance (BRTA) · ± eHealth Group, Bioengineering Area, Biogipuzkoa Health Research Institute

Computational Pathology Pathology Foundation Models Oncology Multiple Instance Learning Whole-Slide Image Analysis

Apr 22, 2026cs.CV

A Digital Pathology Resource for Liver Cancer Quantification with Datasets, Benchmarks, and Tools

Liver cancer, especially hepatocellular carcinoma (HCC), imposes a substantial global disease burden. Accurate diagnosis and prognostic assessment directly influence treatment selection and patient survival, and pathological examination remains the gold standard for liver cancer diagnosis. Identifying diverse tissue components and pathological subtypes on histopathology slides is crucial for estimating postoperative recurrence risk and overall prognosis. However, most publicly available resources are still provided at the whole-slide image (WSI) level, and well-annotated datasets for fine-grained tissue component identification in liver cancer are scarce, which hinders reproducible model development and the deployment of quantitative analysis tools. To address this gap, we release HepatoBench, a patch-level image database for liver cancer with annotations for seven key tissue categories. Based on HepatoBench, we train and open-source a deep learning classification model as a tissue recognition tool. Furthermore, we train a WSI-level tumor/non-tumor segmentation model to automatically localize lesion regions across entire slides. By integrating the patch-level tissue classifier with the WSI-level segmentation model, we build HepatoQuant, an end-to-end, disease-specific regional quantification tool for liver cancer, enabling a unified workflow from WSIs to tissue composition parsing and quantitative statistics. We also open-source HepatoBench, the benchmarking protocol, and supporting tools, providing a solid foundation for automated regional quantification and fair method comparison in liver cancer pathology.

Ying Xiao, Shimiao Tang, Xitong Ling +11

Department of Pathology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China · Shenzhen International Graduate School, Tsinghua University, Shenzhen, China

Computational Pathology Image Segmentation Histopathology Image Segmentation Oncology Histopathology Image Classification Medical Image Benchmarks+1

Apr 21, 2026cs.CV

Unified Multi-Foundation-Model Slide Representation for Pan-Cancer Recognition and Text-Guided Tumor Localization

The expanding ecosystem of pathology foundation models has produced powerful but fragmented tile-level representations, limiting their use in clinical tasks that require unified slide-level reasoning and interpretable linkage to clinically meaningful information. We present ASTRA, a pan-cancer framework that integrates heterogeneous foundation-model representations into a shared slide-level representation space and semantically grounds that space using structured pathology annotation fields, including classification category, cancer type, and anatomic site. ASTRA combines sparse mixture-of-experts contextualization, masked multi-model reconstruction, and contrastive alignment to structured pathology prompts to learn slide representations that support 4-category classification, 3-class solid tumor typing, 16-class cancer typing, and text-guided tumor localization without pixel-level supervision. Developed on a CHTN cohort of 10,359 whole-slide images (WSIs) spanning 16 tumor types, ASTRA consistently improves pan-cancer classification across four pathology foundation-model backbones, achieving up to 97.8% macro-AUC for 4-category classification, 99.7% for 3-class solid tumor typing, and 99.2% for 16-class cancer typing. For tumor localization, ASTRA achieves a mean Dice of 0.897 on an annotated in-domain CHTN subset (n = 380) spanning 16 cancer types and 0.738 on an external TCGA cohort (n = 1,686) spanning four cancer types. These results demonstrate that minimal structured pathology annotation fields derived from slide-level metadata can provide effective semantic supervision for unified slide representation learning, enabling both pan-cancer prediction and weakly supervised tumor localization within a single framework.

Tianyang Wang, Ziyu Su, Abdul Rehman Akbar +6

Department of Pathology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA · Department of Biomedical Engineering, The Ohio State University, Columbus, OH, USA

Pathology Foundation Models Oncology Histopathology Image Classification Medical Image Representation Learning Whole-Slide Image Analysis

Apr 21, 2026cs.CV

Attend what matters: Leveraging vision foundational models for breast cancer classification using mammograms

Vision Transformers

(\texttt{ViT})

have become the architecture of choice for many computer vision tasks, yet their performance in computer-aided diagnostics remains limited. Focusing on breast cancer detection from mammograms, we identify two main causes for this shortfall. First, medical images are high-resolution with small abnormalities, leading to an excessive number of tokens and making it difficult for the softmax-based attention to localize and attend to relevant regions. Second, medical image classification is inherently fine-grained, with low inter-class and high intra-class variability, where standard cross-entropy training is insufficient. To overcome these challenges, we propose a framework with three key components: (1) Region of interest

(\texttt{RoI})

based token reduction using an object detection model to guide attention; (2) contrastive learning between selected

\texttt{RoI}

to enhance fine-grained discrimination through hard-negative based training; and (3) a

\texttt{DINOv2}

pretrained

\texttt{ViT}

that captures localization-aware, fine-grained features instead of global

\texttt{CLIP}

representations. Experiments on public mammography datasets demonstrate that our method achieves superior performance over existing baselines, establishing its effectiveness and potential clinical utility for large-scale breast cancer screening. Our code is available for reproducibility here: https://aih-iitd.github.io/publications/attend-what-matters

Samyak Sanghvi, Piyush Miglani, Sarvesh Shashikumar +3

Department of Computer Science and Engineering, IIT Delhi, New Delhi, India · Yardi School of AI, IIT Delhi, New Delhi, India · Department of Radiodiagnosis, PGIMER Chandigarh, Chandigarh, India

Medical Imaging Vision Foundation Model Adaptation Medical Image Classification Mammography Oncology

Apr 18, 2026cs.CV

Multimodal Fusion of Histopathology Images and Electronic Health Records for Early Breast Cancer Diagnosis

Breast cancer is a leading cause of cancer-related mortality worldwide, and timely accurate diagnosis is critical to improving survival outcomes. While convolutional neural networks (CNNs) have demonstrated strong performance on histopathology image classification, and machine learning models on structured electronic health records (EHR) have shown utility for clinical risk stratification, most existing work treats these modalities in isolation. This paper presents a systematic multimodal framework that integrates patch-level histopathology features from the BreCaHAD dataset with structured clinical data from MIMIC-IV. We train and evaluate unimodal image models (a simple CNN baseline and ResNet-18 with transfer learning), unimodal tabular models (XGBoost and a multilayer perceptron), and an intermediate-fusion model that concatenates latent representations from both modalities. ResNet-18 achieves near-perfect accuracy (1.000) and AUC (1.000) on three-class patch-level classification, while XGBoost achieves 98% accuracy on the EHR prediction task. The intermediate fusion model yields a macro-average AUC of 0.997, outperforming all unimodal baselines and delivering the largest improvements on the diagnostically critical but class-imbalanced mitosis category (AUC 0.994). Grad-CAM and SHAP interpretability analyses validate that model decisions align with established pathological and clinical criteria. Our results demonstrate that multimodal integration delivers meaningful improvements in both predictive performance and clinical transparency.

Aditya Shribhagwan Khandelwal, Mohammad Samar Ansari, Asra Aslam

University of Sheffield, UK · University of Chester, UK

Breast Cancer Computational Pathology Multimodal Classification Oncology Histopathology Image Classification Multimodal Fusion

Apr 17, 2026cs.LG

Graph Transformer-Based Pathway Embedding for Cancer Prognosis

Accurate prediction of cancer progression remains a challenge due to the high heterogeneity of molecular omics data across patients. While biologically informed models have improved the interpretability of these predictions, a persistent limitation lies in how they encode individual genes to construct pathway representations. Existing hierarchical models typically derive gene features by directly mapping raw molecular inputs, whereas integration frameworks often rely on simple statistical aggregations of patient-level signals. These approaches often fail to explicitly learn a shared base representation for each gene, thereby limiting the expressiveness and biological accuracy of downstream pathway embeddings. To address this, we introduce PATH, a modulation-based, patient-conditioned gene embedding strategy. PATH represents a paradigm shift by starting from a shared base embedding for each gene, preserving a stable biological identity across the population, and then dynamically adapting it using patient-specific copy number variation (CNV) and mutation signals. This allows the model to capture subtle individual molecular variations while maintaining a consistent latent understanding of the gene itself. We integrate PATH into a graph transformer framework that models interactions among biologically connected pathways through pathway-guided attention. Across pancancer metastasis prediction, PATH achieves an F1 score of 0.8766, representing an 8.8 percent improvement over the current SOTA multi-omics benchmarks. Beyond superior predictive accuracy, our approach identifies biologically meaningful pathways and, crucially, reveals disease-state-specific pathway rewiring, offering new insights into the evolving pathway-pathway interactions that drive cancer progression.

Koushik Howlader, Md Tauhidul Islam, Wei Le

Iowa State University, Iowa, USA · Stanford University, CA, USA

Cancer Genomics Cancer Survival Prediction Clinical Outcome Prediction Oncology

Apr 17, 2026cs.CV

Early Detection of Acute Myeloid Leukemia (AML) Using YOLOv12 Deep Learning Model

Acute Myeloid Leukemia (AML) is one of the most life-threatening type of blood cancers, and its accurate classification is considered and remains a challenging task due to the visual similarity between various cell types. This study addresses the classification of the multiclasses of AML cells Utilizing YOLOv12 deep learning model. We applied two segmentation approaches based on cell and nucleus features, using Hue channel and Otsu thresholding techniques to preprocess the images prior to classification. Our experiments demonstrate that YOLOv12 with Otsu thresholding on cell-based segmentation achieved the highest level of validation and test accuracy, both reaching 99.3%.

Enas E. Ahmed, Salah A. Aly, Mayar Moner

Biomedical and Systems Dept. Faculty of Engineering Cairo University Giza, Egypt · CS & Math Branch Faculty of Science Fayoum University Fayoum, Egypt · Biotechnology Dept. Faculty of Agriculture Cairo University Giza, Egypt

Medical Image Classification Multiclass Classification Oncology

Apr 17, 2026cs.CV

Ranking XAI Methods for Head and Neck Cancer Outcome Prediction

For head and neck cancer (HNC) patients, prognostic outcome prediction can support personalized treatment strategy selection. Improving prediction performance of HNC outcomes has been extensively explored by using advanced artificial intelligence (AI) techniques on PET/CT data. However, the interpretability of AI remains a critical obstacle for its clinical adoption. Unlike previous HNC studies that empirically selected explainable AI (XAI) techniques, we are the first to comprehensively evaluate and rank 13 XAI methods across 24 metrics, covering faithfulness, robustness, complexity and plausibility. Experimental results on the multi-center HECKTOR challenge dataset show large variations across evaluation aspects among different XAI methods, with Integrated Gradients (IG) and DeepLIFT (DL) consistently obtained high rankings for faithfulness, complexity and plausibility. This work highlights the importance of comprehensive XAI method evaluation and can be extended to other medical imaging tasks.

Baoqiang Ma, Djennifer K. Madzia-Madzou, Rosa C. J. Kraaijveld +1

Image Sciences Institute, University Medical Center Utrecht

Gradient-Based Attribution Cancer Survival Prediction Oncology Explainable Medical Image Analysis Explainability Evaluation

Apr 17, 2026eess.IV

Topology-Driven Fusion of nnU-Net and MedNeXt for Accurate Brain Tumor Segmentation on Sub-Saharan Africa Dataset

Accurate automatic brain tumor segmentation in Low and Middle-Income (LMIC) countries is challenging due to the lack of defined national imaging protocols, diverse imaging data, extensive use of low-field Magnetic Resonance Imaging (MRI) scanners and limited health-care resources. As part of the Brain Tumor Segmentation (BraTS) Africa 2025 Challenge, we applied topology refinement to the state-of-the-art segmentation models like nnU-Net, MedNeXt, and a combination of both. Since the BraTS-Africa dataset has low MRI image quality, we incorporated the BraTS 2025 challenge data of pre-treatment adult glioma (Task 1) to pre-train the segmentation model and use it to fine-tune on the BraTS-Africa dataset. We added an extra topology refinement module to address the issue of deformation in prediction that arose due to topological error. With the introduction of this module, we achieved a better Normalized Surface Distance (NSD) of 0.810, 0.829, and 0.895 on Surrounding Non-Enhancing FLAIR Hyperintensity (SNFH) , Non-Enhancing Tumor Core (NETC) and Enhancing tumor (ET).

Prabin Bohara, Pralhad Kumar Shrestha, Arpan Rai +8

Institute of Engineering, Thapathali Campus, Nepal · Gandaki College of Engineering and Science, Pokhara University, Pokhara, Nepal · Nepal Engineering College, Changunarayan-4, Bhaktapur, Nepal +9

Medical Image Segmentation Oncology Semantic Segmentation Brain MRI Brain Tumor Segmentation

Apr 17, 2026cs.LG

TwinTrack: Post-hoc Multi-Rater Calibration for Medical Image Segmentation

Pancreatic ductal adenocarcinoma (PDAC) segmentation on contrast-enhanced CT is inherently ambiguous: inter-rater disagreement among experts reflects genuine uncertainty rather than annotation noise. Standard deep learning approaches assume a single ground truth, producing probabilistic outputs that can be poorly calibrated and difficult to interpret under such ambiguity. We present TwinTrack, a framework that addresses this gap through post-hoc calibration of ensemble segmentation probabilities to the empirical mean human response (MHR) -the fraction of expert annotators labeling a voxel as tumor. Calibrated probabilities are thus directly interpretable as the expected proportion of annotators assigning the tumor label, explicitly modeling inter-rater disagreement. The proposed post-hoc calibration procedure is simple and requires only a small multi-rater calibration set. It consistently improves calibration metrics over standard approaches when evaluated on the MICCAI 2025 CURVAS-PDACVI multi-rater benchmark.

Tristan Kirscher, Alexandra Ertl, Klaus Maier-Hein +3

ICube, Institut Strauss · ICube Laboratory, CNRS UMR-7357, University of Strasbourg, Strasbourg, France · CLCC Institut Strauss, Strasbourg, France +6

Image Segmentation Post-Hoc Calibration Medical Image Segmentation Oncology Segmentation Uncertainty Estimation

Apr 7, 2026q-bio.GN

Transcriptomic Models for Immunotherapy Response Prediction Show Limited Cross-cohort Generalisability

Immune checkpoint inhibitors (ICIs) have transformed cancer therapy; yet substantial proportion of patients exhibit intrinsic or acquired resistance, making accurate pre-treatment response prediction a critical unmet need. Transcriptomics-based biomarkers derived from bulk and single-cell RNA sequencing (scRNA-seq) offer a promising avenue for capturing tumour-immune interactions, yet the cross-cohort generalisability of existing prediction models remains unclear.We systematically benchmark nine state-of-the-art transcriptomic ICI response predictors, five bulk RNA-seq-based models (COMPASS, IRNet, NetBio, IKCScore, and TNBC-ICI) and four scRNA-seq-based models (PRECISE, DeepGeneX, Tres and scCURE), using publicly available independent datasets unseen during model development. Overall, predictive performance was modest: bulk RNA-seq models performed at or near chance level across most cohorts, while scRNA-seq models showed only marginal improvements. Pathway-level analyses revealed sparse and inconsistent biomarker signals across models. Although scRNA-seq-based predictors converged on immune-related programs such as allograft rejection, bulk RNA-seq-based models exhibited little reproducible overlap. PRECISE and NetBio identified the most coherent immune-related themes, whereas IRNet predominantly captured metabolic pathways weakly aligned with ICI biology. Together, these findings demonstrate the limited cross-cohort robustness and biological consistency of current transcriptomic ICI prediction models, underscoring the need for improved domain adaptation, standardised preprocessing, and biologically grounded model design.

Yuheng Liang, Lucy Chhuo, Ahmadreza Argha +8

UNSW BioMedical Machine Learning Lab (BML), School of Biomedical Engineering, UNSW Sydney, Sydney, NSW, 2052, Australia · Garvan Institute of Meidical Research, Sydney, NSW, 2000, Australia · School of Biomedical Engineering, UNSW, Sydney, NSW, 2052, Australia +7

Clinical Outcome Prediction Oncology Single-Cell Transcriptomics Single-Cell RNA Sequencing Cross-Dataset Generalization

Mar 3, 2026cs.CV

BRIGHT: A Collaborative Generalist-Specialist Foundation Model for Breast Pathology

Generalist pathology foundation models (PFMs), pretrained on large-scale multi-organ datasets, have demonstrated remarkable predictive capabilities across diverse clinical applications. However, their proficiency on the full spectrum of clinically essential tasks within a specific organ system remains an open question due to the lack of large-scale validation cohorts for a single organ as well as the absence of a tailored training paradigm that can effectively translate broad histomorphological knowledge into the organ-specific expertise required for specialist-level interpretation. In this study, we propose BRIGHT, the first PFM specifically designed for breast pathology, trained on over 51,000 breast whole-slide images derived from a cohort of over 40,000 patients across 19 hospitals. BRIGHT employs a collaborative generalist-specialist framework to capture both universal and organ-specific features. To comprehensively evaluate the performance of PFMs on breast oncology, we curate the largest multi-institutional cohorts to date for downstream task development and evaluation, comprising over 25,000 WSIs across 10 hospitals. The validation cohorts cover the full spectrum of breast pathology across 25 distinct clinical tasks spanning diagnosis, biomarker prediction, treatment response and survival prediction. Extensive experiments demonstrate that BRIGHT outperforms five leading generalist PFMs, achieving state-of-the-art (SOTA) performance in 25 of 25 internal validation tasks and in 4 of 11 external validation tasks with excellent heatmap interpretability. By evaluating on large-scale validation cohorts, this study not only demonstrates BRIGHT's clinical utility in breast oncology but also validates a collaborative generalist-specialist paradigm, providing a scalable template for developing PFMs on a specific organ system, accelerating the translation of foundation models into ...

Xiaojing Guo, Jiatai Lin, Yumian Jia +39

Breast Cancer Healthcare Pathology Foundation Models Oncology Whole-Slide Image Analysis

Feb 28, 2026cs.CL

From Literature to Hypotheses: An AI Co-Scientist System for Biomarker-Guided Drug Combination Hypothesis Generation

The rapid growth of biomedical evidence makes it difficult to translate biomarker mechanisms into actionable drug combination hypotheses. We present CoDHy, an interactive AI co-scientist for biomarker-guided hypothesis generation in oncology. CoDHy constructs task-specific knowledge graphs from curated databases and biomedical literature, then combines graph embeddings with agent-based reasoning to generate, validate, and rank evidence-grounded drug combinations. Through a web interface, researchers specify the biomarker, cancer context, and literature scope; inspect supporting evidence and intermediate results; and iteratively refine the generated hypotheses. The demonstration presents CoDHy's end-to-end workflow and shows how researchers can interactively explore and compare mechanistically supported drug combinations while remaining in control of hypothesis prioritization.

Raneen Younis, Suvinava Basak, Lukas Chavez +1

Peter L. Reichertz Institute for Medical Informatics (PLRI), Hannover Medical School · Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine (CAIMed) · Sanford Burnham Prebys (SBP) Medical Discovery Institute

Scientific Hypothesis Generation Oncology Drug Discovery Biomedical KGs

Feb 17, 2026cs.CV

Context-aware Skin Cancer Epithelial Cell Classification with Scalable Graph Transformers

Whole-slide images (WSIs) from cancer patients contain rich information that can be used for medical diagnosis or to follow treatment progress. To automate their analysis, numerous deep learning methods based on convolutional neural networks and Vision Transformers have been developed and have achieved strong performance in segmentation and classification tasks. However, due to the large size and complex cellular organization of WSIs, these models rely on patch-based representations, losing vital tissue-level context. We propose using scalable Graph Transformers on a full-WSI cell graph for classification. We evaluate this methodology on a challenging task: the classification of healthy versus tumor epithelial cells in cutaneous squamous cell carcinoma (cSCC), where both cell types exhibit very similar morphologies and are therefore difficult to differentiate for image-based approaches. We first compared image-based and graph-based methods on a single WSI. Graph Transformer models SGFormer and DIFFormer achieved balanced accuracies of

85.2 \pm 1.5

(

\pm

standard error) and

85.1 \pm 2.5

in 3-fold cross-validation, respectively, whereas the best image-based method reached

81.2 \pm 3.0

. By evaluating several node feature configurations, we found that the most informative representation combined morphological and texture features as well as the cell classes of non-epithelial cells, highlighting the importance of the surrounding cellular context. We then extended our work to train on several WSIs from several patients. To address the computational constraints of image-based models, we extracted four

2560 \times 2560

pixel patches from each image and converted them into graphs. In this setting, DIFFormer achieved a balanced accuracy of

83.6 \pm 1.9

(3-fold cross-validation), while the state-of-the-art image-based model CellViT256 reached

78.1 \pm 0.5

.

Lucas Sancéré, Noémie Moreau, Katarzyna Bozek

Faculty of Mathematics and Natural Sciences, University of Cologne, Cologne, North Rhine-Westphalia, Germany · Institute for Biomedical Informatics, Faculty of Medicine and University Hospital Cologne, University of Cologne, North Rhine-Westphalia, Germany · Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, North Rhine-Westphalia, Germany +1

Computational Pathology Oncology Histopathology Image Classification Graph Transformer Whole-Slide Image Analysis

Jan 17, 2026cs.CL

Mapping the maturation of TCM as an adjuvant to radiotherapy

The integration of complementary medicine into oncology represents a paradigm shift that has seen to increasing adoption of Traditional Chinese Medicine (TCM) as an adjuvant to radiotherapy. About twenty-five years since the formal institutionalization of integrated oncology, it is opportune to synthesize the trajectory of evidence for TCM as an adjuvant to radiotherapy. Here we conduct a large-scale analysis of 69,745 publications (2000 - 2025), emerging a cyclical evolution defined by coordinated expansion and contraction in publication output, international collaboration, and funding commitments that mirrors a define-ideate-test pattern. Using a theme modeling workflow designed to determine a stable thematic structure of the field, we identify five dominant thematic axes - cancer types, supportive care, clinical endpoints, mechanisms, and methodology - that signal a focus on patient well-being, scientific rigor and mechanistic exploration. Cross-theme integration of TCM is patient-centered and systems-oriented. Together with the emergent cycles of evolution, the thematic structure demonstrates progressive specialization and potential defragmentation of the field or saturation of existing research agenda. The analysis points to a field that has matured its current research agenda and is likely at the cusp of something new. Additionally, the field exhibits positive reporting of findings that is homogeneous across publication types, thematic areas, and the cycles of evolution suggesting a system-wide positive reporting bias agnostic to structural drivers.

P. Bilha Githinji, Aikaterini Melliou, Xi Yuan +8

Guangdong Provincial Laboratory of Traditional Chinese Medicine, Hengqin, Guangdong, China · Affiliated Fifth Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China

Oncology Bibliometric Analysis

Dec 8, 2025cs.LG

CLARITY: Medical World Model for Guiding Treatment Decisions by Modeling Context-Aware Disease Trajectories in Latent Space

Clinical decision-making in oncology requires predicting dynamic disease evolution, a task current static AI predictors cannot perform. While world models (WMs) offer a paradigm for generative prediction, existing medical applications remain limited. Existing methods often rely on stochastic diffusion models, focusing on visual reconstruction rather than causal, physiological transitions. Furthermore, in medical domain, models like MeWM typically ignore patient-specific temporal and clinical contexts and lack a feedback mechanism to link predictions to treatment decisions. To address these gaps, we introduce CLARITY, a medical world model that forecasts disease evolution directly within a structured latent space. It explicitly integrates time intervals (temporal context) and patient-specific data (clinical context) to model treatment-conditioned progression as a smooth, interpretable trajectory, and thus generate physiologically faithful, individualized treatment plans. Finally, CLARITY introduces a novel prediction-to-decision framework, translating latent rollouts into transparent, actionable recommendations. CLARITY demonstrates state-of-the-art performance in treatment planning. On the MU-Glioma-Post dataset, our approach outperforms recent MeWM by 12%, and significantly surpasses all other medical-specific large language models.

Tianxingjian Ding, Yuanhao Zou, Chen Chen +2

Institute of Artificial Intelligence, University of Central Florida

Healthcare Clinical Decision Support Clinical Decision-Making Oncology Latent World Models

Nov 24, 2025cs.CV

OncoVision: Integrating Mammography and Clinical Data through Attention-Driven Multimodal AI for Enhanced Breast Cancer Diagnosis

OncoVision is a privileged-information training framework that uses mammography images and clinical features during training and performs inference from mammographic images alone. Employing an attention-based encoder-decoder backbone, it jointly segments four regions of interest (masses, calcifications, axillary findings, and breast tissue) with accuracy exceeding the nnU-Net baseline and predicts ten structured clinical features, including BI-RADS category. We developed two late-fusion strategies, Independent and Dependent, that integrate imaging, radiomic, and clinical information during training to improve diagnostic precision and potentially reduce inter-observer variability. Radiomic features extracted from predicted masks provide shape, intensity, and texture descriptors that complement the learned CNN representations. We evaluated OncoVision in a retrospective multi-reader study with six board-certified radiologists, assessing diagnostic confidence, reading time, and segmentation accuracy with and without AI assistance. In a paired reader-assistance evaluation, OncoVision was associated with higher diagnostic confidence for junior and senior radiologists, reduced reading time by up to 61%, and achieved segmentation accuracy comparable to or exceeding that of radiologists for mass lesions. We operationalized OncoVision as a secure web application, now deployed at a partner hospital, that generates structured reports with dual-confidence scoring and attention-weighted visualizations for real-time diagnostic support. The platform is designed for integration into clinical workflows, with the goal of supporting screening access in underprivileged regions. By combining accurate segmentation with clinical intuition, OncoVision advances AI-assisted mammographic interpretation, offering a scalable and accessible approach to earlier and more consistent image interpretation.

Istiak Ahmed, Galib Ahmed, K. Shahriar Sanjid +10

Department Electrical and Computer Engineering, North South University, Dhaka, 1229, Bangladesh. · Big-Matrix Lab, North South University, Dhaka, 1229, Bangladesh. · Department of Mathematics and Physics, North South University, Dhaka, 1229, Bangladesh. +7

Breast Cancer Medical Image Segmentation Mammography Oncology Learning Using Privileged Information

Nov 22, 2025cs.CV

Together, Then Apart: Balancing Alignment and Distinctiveness for Multimodal Survival Analysis

Multimodal survival analysis aims to improve cancer prognosis using heterogeneous biomedical data, such as histopathology images and genomic profiles. A common strategy is to align representations across modalities so that shared signals can be captured. However, strong cross-modal alignment can also remove modality-specific evidence that is critical for survival prediction. In this paper, we revisit multimodal survival learning from a simple observation: effective models should first discover shared patterns across modalities, and then preserve modality-specific signals. This motivates a representation learning principle that we refer to as Together Then Apart. Based on this idea, we propose TTA, a framework that balances cross-modal alignment and representation distinctiveness. TTA first performs prototype-based alignment to capture shared survival-related structures between modalities. It then encourages modality-specific distinctiveness through an anchor-guided contrastive objective. To further account for modality imbalance and noisy correspondences, we model cross-modal interactions using unbalanced optimal transport. We evaluate the proposed approach on multiple TCGA cancer cohorts with paired histopathology and genomic data. TTA consistently improves survival prediction over recent multimodal survival models. Moreover, the learned prototype structures reveal interpretable cross-modal patterns associated with clinical outcomes.

Wenjing Liu, Qin Ren, Wen Zhang +2

Stony Brook University, Stony Brook, NY, USA · Johns Hopkins University, Baltimore, MD, USA · Brookhaven National Laboratory, Upton, NY, USA

Cancer Survival Prediction Survival Analysis Cross-Modal Alignment Oncology Multimodal Survival Analysis Multimodal Contrastive Learning

Oct 13, 2025cs.CV

Benchmarking Deep Learning Models for Laryngeal Cancer Staging Using the LaryngealCT Dataset

Laryngeal cancer imaging research lacks standardised public datasets to enable reproducible deep learning (DL) model development. We present LaryngealCT, a curated benchmark of 1,029 computed tomography (CT) scans aggregated from six collections from The Cancer Imaging Archive (TCIA). Uniform 1 mm isotropic volumes of interest encompassing the larynx were extracted using a weakly supervised parameter search framework validated by clinical experts. Six 3D DL architectures (custom 3D CNN, ResNet18,50,101, DenseNet121 and MedicalNet-pretrained ResNet50) were benchmarked on (i) early (Tis,T1,T2) vs. advanced (T3,T4) and (ii) T4 vs. non-T4 classification tasks. On the independent test set, the 3D CNN achieved the strongest overall performance across global and per-class metrics (Accuracy 0.854, F1-macro 0.841) in early vs. advanced classification. In the T4 task, AU-ROC values exceeded 0.82 for most models, but sensitivity for T4 disease remained limited (less than or equal to 0.412), with ResNet101 showing the most promising calibrated T4 recall (0.706. Model explainability assessed using GradCAMpp with thyroid cartilage overlays for T4 classification task revealed anatomically plausible peri-cartilage activations, although spatial overlap was modest. Through open-source data, pretrained models, and integrated explainability tools, LaryngealCT offers a reproducible foundation for AI-driven research to support future clinical decision-making in laryngeal oncology.

Nivea Roy, Son Tran, Atul Sajjanhar +4

School of Information Technology, Deakin University, Burwood, Australia · Department of Head and Neck Surgery, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India · Department of Radiodiagnosis and Imaging, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India +1

Medical Image Classification Oncology Medical Image Benchmarks

May 6, 2025cs.CV

Synergistic Vision-Language Reinforcement Enables Scalable On-Demand Analysis across Diverse Clinical Tasks

Accurate delineation of tumors and surrounding organs-at-risk is essential for radiotherapy, surgery and treatment response assessment, yet remains time-consuming and expertise-intensive. Existing artificial intelligence systems often require manual spatial prompts or task-specific retraining, while generic class labels provide limited semantic grounding for heterogeneous disease targets. Here we present SyRe, a promptable segmentation foundation model based on Synergistic vision-language Reinforcement. SyRe strengthens bidirectional interaction between visual and linguistic representations to improve semantically grounded spatial understanding. To support large-scale training, we introduce the Color Region Description strategy and construct SyReData, comprising 20 million image-mask-description triplets across 9 modalities and 229 segmentation tasks. Training with diversified prompt forms further enables open-ended prompting, invalid-prompt rejection and flexible switching between single- and multi-target analysis. SyRe achieves accurate text-prompted segmentation across diverse clinical scenarios, with particularly strong performance on disease-related targets. Across 28 unseen external datasets, including 20 cancer types and multinational in-house cohorts, SyRe generalizes robustly under real-world distribution shifts. SyRe-generated masks also preserve clinically relevant quantitative information in pathology and yield radiomics features that stratify survival and improve prognostic modeling across five retrospective CT and MRI tumor cohorts. Finally, clinician-in-the-loop refinement enables efficient case-level correction when greater precision is required. These results establish SyRe as a generalizable foundation for scalable quantitative oncology and clinician-guided segmentation refinement.

Haonan Wang, Jiaji Mao, Lehan Wang +11

Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Hong Kong SAR · Department of Radiology, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China · Department of Computer Science and Engineering, The Hong Kong University of Science and Technology, Hong Kong SAR

Image Segmentation Medical Imaging Foundation Models Text-Guided Image Segmentation Medical VLMs Medical Image Segmentation Oncology+1

Apr 18, 2025cs.CV

Towards Accurate and Lightweight Peripheral Neuroblastic Tumor Diagnosis via Contrastive Multi-scale Pathological Image Analysis

Peripheral neuroblastic tumors (pNTs) are among the most common extracranial solid tumors in children, and accurate pathological subtyping is important for risk stratification and treatment planning. However, pNT subtyping on hematoxylin-eosin whole-slide images (WSIs) remains challenging because of limited pediatric tumor cohorts, marked histological heterogeneity, inter-observer variability, and the computational burden of existing WSI classifiers. To address these challenges, we propose CoPath, a framework consisting of CoHisNet and PathVote. CoHisNet is a lightweight multi-scale feature-fusion network for patch-level histopathological classification. By replacing the multilayer perceptron components in Swin Transformer blocks and the classification head with Kolmogorov-Arnold Network layers, CoHisNet improves nonlinear feature modeling under a compact architecture. Its multi-scale interaction and contrast-driven feature-enhancement design enables the model to capture both tissue-level structures and fine-grained cellular morphology. PathVote further incorporates pathology-informed tissue-component priors to aggregate patch-level predictions into WSI-level decisions. We validated CoPath on a private two-branch PpNTs cohort and the public BreakHis breast cancer histopathology dataset. Experimental results show that CoPath achieves competitive or superior performance compared with general image classifiers, pathology foundation models under linear probing, and pathology-specific classification models, while maintaining substantially lower computational complexity. The source code is available at https://github.com/JSLiam94/CoPath.

Zhu Zhu, Shuo Jiang, Jingyuan Zheng +7

Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China · Hangzhou Dianzi University, Hangzhou 310018, China · Chinese University of Hong Kong, Hong Kong SAR, China +1

Computational Pathology Oncology Histopathology Image Classification Whole-Slide Image Analysis